The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

According to a statement that was released by Novavax on Wednesday, it appears that the Food and Drug Administration (FDA) of the United States of America will shortly give the COVID-19 vaccine its ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.

Cambridge’s DIOSynVax and Singapore’s ACM Biolabs will be jointly developing a next-generation universal bird flu vaccine with the potential for mucosal delivery to combat the next pandemic. This ...

Moderna (NasdaqGS:MRNA) experienced a 10% share price increase, coinciding with broader market gains but slightly below the Nasdaq Composite's 5% rise. Despite the market being uplifted by strong ...